NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
16.86
+0.38 (2.31%)
At close: Nov 20, 2024, 4:00 PM
17.08
+0.22 (1.30%)
Pre-market: Nov 21, 2024, 7:41 AM EST
NovoCure Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for NovoCure stock have an average target of 26.6, with a low estimate of 17 and a high estimate of 40. The average target predicts an increase of 57.77% from the current stock price of 16.86.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NovoCure stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 4 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +77.94% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $24 → $30 | Hold → Strong Buy | Upgrades | $24 → $30 | +77.94% | Oct 16, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $21 → $18 | Hold | Maintains | $21 → $18 | +6.76% | Oct 1, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $42 → $40 | Buy | Maintains | $42 → $40 | +137.25% | Jul 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +42.35% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
606.78M
from 509.34M
Increased by 19.13%
Revenue Next Year
639.15M
from 606.78M
Increased by 5.33%
EPS This Year
-1.32
from -1.95
EPS Next Year
-1.53
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 630.0M | 680.5M | 761.4M | ||
| Avg | 606.8M | 639.2M | 702.9M | ||
| Low | 568.4M | 582.1M | 619.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.7% | 12.2% | 19.1% | ||
| Avg | 19.1% | 5.3% | 10.0% | ||
| Low | 11.6% | -4.1% | -3.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.25 | -0.97 | -0.93 | ||
| Avg | -1.32 | -1.53 | -1.44 | ||
| Low | -1.34 | -1.89 | -1.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.